Lexeo Therapeutics, Inc.
LXEO
$5.12
$0.418.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.61% | -10.26% | -10.29% | 60.59% | 242.65% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 88.80% | 12.45% | -28.43% | 7.11% | 100.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.91% | -9.99% | -10.57% | 59.37% | 219.74% |
|
|
|||||
| Total Current Assets | -20.91% | -9.99% | -10.57% | 59.37% | 219.74% |
| Net Property, Plant & Equipment | -5.36% | -3.89% | -2.17% | -3.24% | -2.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -15.49% | -9.45% | -9.94% | 52.50% | 155.48% |
|
|
|||||
| Total Accounts Payable | -23.95% | 46.37% | 34.16% | 13.26% | 42.90% |
| Total Accrued Expenses | -15.35% | 48.15% | -28.99% | 39.96% | -23.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.45% | 0.45% | 2.26% | 0.23% | 0.31% |
| Total Finance Division Other Current Liabilities | 69.49% | 151.82% | -32.52% | -41.16% | 179.80% |
| Total Other Current Liabilities | 69.49% | 151.82% | -32.52% | -41.16% | 179.80% |
| Total Current Liabilities | -14.81% | 42.07% | -12.73% | 25.47% | -25.16% |
|
|
|||||
| Total Current Liabilities | -14.81% | 42.07% | -12.73% | 25.47% | -25.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.05% | -5.63% | -5.14% | -4.52% | -4.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -12.85% | 27.64% | -10.56% | 15.16% | -19.16% |
|
|
|||||
| Common Stock & APIC | 0.90% | 0.99% | 0.84% | 30.84% | 5,996.49% |
| Retained Earnings | -10.20% | -13.12% | -10.44% | -11.92% | -8.46% |
| Treasury Stock & Other | -823.08% | 0.00% | -- | -- | -- |
| Total Common Equity | -16.14% | -15.53% | -9.84% | 61.14% | 169.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.14% | -15.53% | -9.84% | 61.14% | 169.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.14% | -15.53% | -9.84% | 61.14% | 410.84% |
|
|
|||||